Elite Pharmaceuticals, Inc. Accounts Payable
Elite Pharmaceuticals, Inc. (ELTP) had Accounts Payable of $5.59 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $5.59M.
- 2026-03-31: Accounts Payable, Current $6.05M.
- 2025-12-31: Accounts Payable, Current $6.52M.
- 2025-09-30: Accounts Payable, Current $3.42M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $5.59M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.05M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $6.52M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $3.42M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $5.09M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.96M 10-K · filed 2026-06-29 |
| 2024-12-31 | $5.84M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $1.98M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.61M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.71M 10-K · filed 2025-06-30 |
| 2023-12-31 | $2.89M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $3.61M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.87M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.45M 10-K · filed 2024-07-01 |
| 2022-12-31 | $1.47M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $1.72M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.61M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.43M 10-K · filed 2023-06-29 |
| 2021-12-31 | $1.28M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $1.79M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.05M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $929.69K 10-K · filed 2022-06-29 |
| 2020-12-31 | $700.90K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $589.43K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.07M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.58M 10-K · filed 2021-06-14 |
| 2019-12-31 | $986.02K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $1.73M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.09M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.38M 10-K · filed 2020-06-29 |
| 2018-12-31 | $2.31M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $1.14M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.07M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.66M 10-K · filed 2019-06-21 |
| 2017-12-31 | $1.44M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $860.09K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $880.71K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.05M 10-K · filed 2018-06-14 |
| 2016-12-31 | $1.36M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $2.28M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.46M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.80M 10-K · filed 2017-06-14 |
| 2015-03-31 | $3.38M 10-K · filed 2016-06-15 |